David Hirsch
Director/Board Member at RAPID MICRO BIOSYSTEMS, INC.
Net worth: - $ as of 2024-03-30
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Carolyn Helms | F | - |
Longitude Capital Management Co LLC
 Longitude Capital Management Co LLC Investment ManagersFinance Longitude Capital Management Co LLC (Longitude Capital) is a venture capital firm founded in 2006 by Juliet Trammenoms Bakker, Patrick Enright, David Hirsch and Marc-Henri Galletti. The firm is headquartered in Menlo Park, California. | 16 years |
| Gabriela Gruia | M | 67 | 2 years | |
| Joseph Ciaffoni | M | 53 | 7 years | |
| Jeffrey Schwartz | M | 45 | 6 years | |
| Robert Spignesi | M | 55 | 10 years | |
| Jonathan Paris | M | 49 | 3 years | |
| Kuo-Shyan Lin | M | - |
Alpha-9 Oncology, Inc.
 Alpha-9 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Alpha-9 Theranostics, Inc. operates as a clinical stage radiopharmaceutical company. It engages in developing breakthrough targeting agents for cancer imaging by positron emission tomography (PET) and therapy using targeted radioisotopes. The company was founded by Fran?ois B?nard, David Perrin, Kuo-Shyan Lin, and Ian McBeath and is headquartered in Vancouver, Canada. | - |
| Inese Lowenstein | F | 51 | 3 years | |
| Scott Sudduth | M | - | 6 years | |
| Francois Bénard | M | - |
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Alpha-9 Theranostics, Inc. operates as a clinical stage radiopharmaceutical company. It engages in developing breakthrough targeting agents for cancer imaging by positron emission tomography (PET) and therapy using targeted radioisotopes. The company was founded by Fran?ois B?nard, David Perrin, Kuo-Shyan Lin, and Ian McBeath and is headquartered in Vancouver, Canada. | - |
| Melinda Litherland | F | 66 | 3 years | |
| Shirley Kuhlmann | F | 40 | 6 years | |
| Michael Wert | M | - |
Longitude Capital Management Co LLC
Longitude Capital Management Co LLC Investment ManagersFinance Longitude Capital Management Co LLC (Longitude Capital) is a venture capital firm founded in 2006 by Juliet Trammenoms Bakker, Patrick Enright, David Hirsch and Marc-Henri Galletti. The firm is headquartered in Menlo Park, California. | 16 years |
| Kirk Malloy | M | 58 | 1 years | |
| cristiana oliveria | F | - |
Longitude Capital Management Co LLC
Longitude Capital Management Co LLC Investment ManagersFinance Longitude Capital Management Co LLC (Longitude Capital) is a venture capital firm founded in 2006 by Juliet Trammenoms Bakker, Patrick Enright, David Hirsch and Marc-Henri Galletti. The firm is headquartered in Menlo Park, California. | 4 years |
| Ciara Kennedy | M | 52 |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | 3 years |
| Loren Wagner | M | - | 3 years | |
| Thomas FitzGerald | M | - | 1 years | |
| Corazon Sanders | M | 67 | 5 years | |
| John Schmid | M | 60 | 6 years | |
| John Fallon | M | 76 | 8 years | |
| David Hoffmann | M | 79 | 7 years | |
| Michael T. Beaulieu | M | - | 2 years | |
| Kathryn Falberg | F | 63 | 6 years | |
| Harold Selick | M | 69 | 7 years | |
| Nat Ricciardi | M | 75 | 8 years | |
| Cynthia Collins | F | 65 | 3 years | |
| Marcea Lloyd | F | 75 | 5 years | |
| John Freund | M | 70 | 10 years | |
| Kumar Brahma | M | - |
Longitude Capital Management Co LLC
Longitude Capital Management Co LLC Investment ManagersFinance Longitude Capital Management Co LLC (Longitude Capital) is a venture capital firm founded in 2006 by Juliet Trammenoms Bakker, Patrick Enright, David Hirsch and Marc-Henri Galletti. The firm is headquartered in Menlo Park, California. | 2 years |
| Sarah Thailing | F | - | 4 years | |
| Lisa Portale | F | - | 5 years | |
| Sean Wirtjes | M | 54 | 6 years | |
| Kristin Martin | F | 49 | 5 years | |
| Karen Basbaum | F | - | 4 years | |
| Sonia Parekh | F | - |
Longitude Capital Management Co LLC
Longitude Capital Management Co LLC Investment ManagersFinance Longitude Capital Management Co LLC (Longitude Capital) is a venture capital firm founded in 2006 by Juliet Trammenoms Bakker, Patrick Enright, David Hirsch and Marc-Henri Galletti. The firm is headquartered in Menlo Park, California. | 4 years |
| David Perrin | M | - |
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Alpha-9 Theranostics, Inc. operates as a clinical stage radiopharmaceutical company. It engages in developing breakthrough targeting agents for cancer imaging by positron emission tomography (PET) and therapy using targeted radioisotopes. The company was founded by Fran?ois B?nard, David Perrin, Kuo-Shyan Lin, and Ian McBeath and is headquartered in Vancouver, Canada. | - |
| Luke Corning | M | 41 | 4 years | |
| Victoria Vezina | F | 56 | 4 years | |
| Charles Baum | M | 65 | 2 years | |
| Michael Reitermann | M | 61 |
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. Miscellaneous Commercial ServicesCommercial Services Alpha-9 Theranostics, Inc. operates as a clinical stage radiopharmaceutical company. It engages in developing breakthrough targeting agents for cancer imaging by positron emission tomography (PET) and therapy using targeted radioisotopes. The company was founded by Fran?ois B?nard, David Perrin, Kuo-Shyan Lin, and Ian McBeath and is headquartered in Vancouver, Canada. | - |
| Harry Leonhardt | M | 67 | 4 years | |
| Michael Wysocki | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Theodore Schroeder | M | 69 |
Zavante Therapeutics, Inc.
 Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zavante Therapeutics, Inc. manufactures pharmaceutical products. Its product ZOLYD is an investigational, first-in-class epoxide antibiotic with a spectrum of bactericidal Gram-negative and Gram-positive activity, including activity against most contemporary MDR strains that threaten hospitalized patients. The company was founded by Cam L. Garner, Evelyn Ellis-Grosse and Theodore R. Schroeder in 2013 and is headquartered in San Diego, CA. | 6 years |
| Adam Daniel Cutler | M | 50 | 4 years | |
| Robert McKague | M | 60 | 3 years | |
| Raymond Chan | M | - |
Harvard Medical School
The Johns Hopkins University
Massachusetts Institute of Technology
| 12 years |
| Mark Iwicki | M | 57 |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | - |
| Cam L. Garner | M | 75 |
Zavante Therapeutics, Inc.
Zavante Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Zavante Therapeutics, Inc. manufactures pharmaceutical products. Its product ZOLYD is an investigational, first-in-class epoxide antibiotic with a spectrum of bactericidal Gram-negative and Gram-positive activity, including activity against most contemporary MDR strains that threaten hospitalized patients. The company was founded by Cam L. Garner, Evelyn Ellis-Grosse and Theodore R. Schroeder in 2013 and is headquartered in San Diego, CA. | - |
| Simo Kamppari | M | - |
Massachusetts Institute of Technology
| 4 years |
| Wesley Chan | M | - |
Massachusetts Institute of Technology
| 5 years |
| Stephanie Thomas | F | - |
Massachusetts Institute of Technology
| 6 years |
| Dong-Sik Kim | M | 54 |
Massachusetts Institute of Technology
| 2 years |
| Paul Carey Konigsberg | M | - |
Massachusetts Institute of Technology
| 4 years |
| Celine Fung | F | - |
Massachusetts Institute of Technology
| 2 years |
| Tri Tran | M | - |
Massachusetts Institute of Technology
| 5 years |
| Dustin Byrne | M | - |
Massachusetts Institute of Technology
| 5 years |
| Hongming Chen | M | 53 |
Massachusetts Institute of Technology
| 3 years |
| Richard J. Nelson | M | - |
Massachusetts Institute of Technology
| 5 years |
| Earl Jones | M | - |
Massachusetts Institute of Technology
| 3 years |
| Jonathan Paul Loflin | M | - |
Massachusetts Institute of Technology
| 5 years |
| Alexander Schmitz | M | 49 | 2 years | |
| Tom Rikert | M | - |
Massachusetts Institute of Technology
| 5 years |
| Hatice Hale Özsoy Biyikli | F | 47 |
Massachusetts Institute of Technology
| 4 years |
| Morten Aleksandr Engel | M | - |
Massachusetts Institute of Technology
| 5 years |
| Muhammad Mohsin Al-Saggaf | M | 56 |
Massachusetts Institute of Technology
| 5 years |
| Rob Burn | M | - |
Massachusetts Institute of Technology
| 5 years |
| Alan Chhabra | M | - |
Massachusetts Institute of Technology
| 5 years |
| Ilya Lisansky | M | - |
Massachusetts Institute of Technology
| 4 years |
| Feng Li | M | 56 |
Massachusetts Institute of Technology
| 4 years |
| Jonathan Lanfear | M | 55 | 6 years | |
| Young Kim | M | - |
Massachusetts Institute of Technology
| 5 years |
| Kenneth Lau | M | 46 |
Massachusetts Institute of Technology
| 4 years |
| Vinay Seth Mohta | M | - |
Massachusetts Institute of Technology
| 5 years |
| Shane M. Farritor | M | - |
Massachusetts Institute of Technology
| 5 years |
| William Feehery | M | 54 |
Massachusetts Institute of Technology
| 5 years |
| Ben Shih | M | - |
Massachusetts Institute of Technology
| 4 years |
| Robert Poor | M | - |
Massachusetts Institute of Technology
| 6 years |
| Benjamin van Roy | M | - |
Massachusetts Institute of Technology
| 4 years |
| Peter Rice | M | - |
Massachusetts Institute of Technology
| 6 years |
| Howard P. Offit | M | - |
The Johns Hopkins University
| 5 years |
| Raj Shah | M | 46 |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | - |
| Mike Capelle | M | - |
Massachusetts Institute of Technology
| 2 years |
| Morten Westye Høegh | M | 51 |
Massachusetts Institute of Technology
| 4 years |
| Mohsin Ansari | M | - |
Massachusetts Institute of Technology
| 2 years |
| Brian Chen | M | - |
Massachusetts Institute of Technology
| 5 years |
| Stephen H. Delity | M | - | - | |
| Sandra Coufal | M | 60 | 10 years | |
| Neil Renninger | M | 49 |
Massachusetts Institute of Technology
| 5 years |
| Gideon Stein | M | - |
Massachusetts Institute of Technology
| 5 years |
| Matthew S. Reynolds | M | - |
Massachusetts Institute of Technology
| 5 years |
| James L. McGrath | M | - |
Massachusetts Institute of Technology
| 5 years |
| Andrea Franz | F | 62 |
Civitas Therapeutics, Inc.
Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | - |
| Kareem Akhtar | M | - |
Massachusetts Institute of Technology
| 5 years |
| Jacob Einhorn | M | - |
The Johns Hopkins University
Massachusetts Institute of Technology
| 6 years |
| Jamie Flinchbaugh | M | - |
Massachusetts Institute of Technology
| 2 years |
| Andra Bolotin | F | 61 |
Massachusetts Institute of Technology
| 2 years |
| Chris Turner | M | - |
Massachusetts Institute of Technology
| 6 years |
| Erik Herzfeld | M | 50 |
The Johns Hopkins University
Massachusetts Institute of Technology
| 6 years |
| Sami Shalabi | M | - |
Massachusetts Institute of Technology
| 5 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 96 | 96.00% |
| Canada | 4 | 4.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Hirsch
- Personal Network
